• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Stimwave

Former Stimwave CEO convicted of healthcare fraud

March 13, 2024 By Sean Whooley

The U.S. Justice Dept. announced last week that a jury found former Stimwave CEO Laura Perryman guilty of healthcare fraud. Damian Williams, U.S. Attorney for the Southern District of New York, last week announced the jury’s verdict. It found Perryman guilty on two counts of an indictment charging her with conspiracy to commit healthcare fraud and […]

Filed Under: Business/Financial News, Implants, Legal News, Neuromodulation/Neurostimulation Tagged With: Stimwave, U.S. Justice Dept. (DOJ)

SEC: former Stimwave CEO defrauded investors out of $41M with fake neuromod implant

December 20, 2023 By Sean Whooley

The SEC charged Laura Perryman, former Stimwave CEO and co-founder, with defrauding investors out of approximately $41 million. Perryman founded and served as CEO of Florida-based Stimwave until her termination in 2019. In February 2020, Stimwave ceased all sales of its high-frequency spinal cord stimulation systems in exchange for the dismissal of a patent infringement lawsuit brought by […]

Filed Under: Business/Financial News, Implants, Legal News, Neurological, Neuromodulation/Neurostimulation, Pain Management Tagged With: Stimwave

DOJ charges former Stimwave CEO over alleged non-functioning neuromod implant

March 9, 2023 By Sean Whooley

The U.S. Justice Dept. (DOJ) announced today that it filed a two-count indictment charging former Stimwave CEO Laura Perryman, claiming a scheme around the company’s neuromodulation technology. Damian Williams, the United States Attorney for the Southern District of New York, Michael J. Driscoll, the Assistant Director in Charge of the New York Field Office of […]

Filed Under: Business/Financial News, Featured, Implants, Legal News, Medicare, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management Tagged With: Federal Bureau of Investigation (FBI), Stimwave, U.S. Department of Justice, U.S. Justice Dept. (DOJ)

Stimwave Technologies names new CEO

April 6, 2020 By Danielle Kirsh

Stimwave Technologies recently announced that it named Aure Bruneau as CEO, effective immediately. Bruneau succeeds Paul LaViolette, who was appointed interim CEO in late 2019. “Are is a perfect match for the next fast-growth chapter at Stimwave,” LaViolette said in a news release. “He is a truly customer-centric leader and will continue our rapid expansion […]

Filed Under: Business/Financial News Tagged With: Stimwave

Stimwave caves in patent spat with Nevro

February 28, 2020 By Nancy Crotti

Stimwave today announced it will cease all sales of its high-frequency spinal cord stimulation systems in exchange for dismissal of a patent infringement lawsuit brought by rival Nevro (NYSE:NVRO). No damages were awarded to Nevro under the settlement. Redwood City, Calif.-based Nevro brought the suit in February 2019, alleging that Stimwave infringed on patents related to […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management, Patent Infringement Tagged With: Nevro Corp., Stimwave

Stimwave Technologies stops commercialization of products in Australia

November 26, 2019 By Sean Whooley

Stimwave Technologies announced today that it is stopping the commercialization of its product lines in Australia until its entire product family can be legally marketed in the country. The neuromodulation therapy alternative developer’s products include the Freedom SCS system and the StimQ PNS system, which are designed to reduce the risks associated with implantable pulse […]

Filed Under: Business/Financial News, Neurological, Neuromodulation/Neurostimulation, News Well, Pain Management, Regulatory/Compliance Tagged With: Stimwave

Stimwave appeals injunction in Nevro patent war

September 25, 2019 By Brad Perriello

Stimwave yesterday appealed a preliminary injunction barring it from using higher-frequency neurostim to treat chronic pain in a patent spat with rival Nevro (NYSE:NVRO). Redwood City, Calif.-based Nevro brought the suit in February, alleging that Stimwave infringed on patents related to Nevro’s Senza system and HF10 therapy. The lawsuit, filed in the U.S. District Court for Delaware, […]

Filed Under: Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management, Patent Infringement Tagged With: Nevro Corp., Stimwave

Nevro wins partial injunction in patent spat with Stimwave

July 25, 2019 By Brad Perriello

A federal judge in Delaware yesterday granted a preliminary injunction to Nevro Corp. (NYSE:NVRO) barring neuromodulation rival Stimwave from using higher-frequency neurostim to treat chronic pain. Redwood City, Calif.-based Nevro brought the suit in February, alleging that Stimwave infringed on patents related to Nevro’s Senza system and HF10 therapy. The lawsuit, which was filed in the U.S. […]

Filed Under: Featured, Legal News, Neuromodulation/Neurostimulation, Wall Street Beat Tagged With: Nevro Corp., Stimwave

Ablative Solutions taps medtech vet Rumrill for CEO | Personnel Moves, July 16, 2019

July 16, 2019 By Brad Perriello

Ablative Solutions tapped 30-year industry veteran Kate Rumrill, the former chief executive at NeoSync, to be its new president & CEO. Rumrill, whose resume includes stints at Covidien, Aspect Medical Systems and Eli Lilly, is slated to keep her seat on NeoSync’s board, San Jose, Calif.-based Ablative Solutions said. The company makes the Peregine renal […]

Filed Under: Business/Financial News, Featured Tagged With: Ablative Solutions, Cantel Medical Corp., Cardinal Health, Glooko, ICU Medical Inc., Intuitive Surgical, Ocular Therapeutix, Orthofix, Personnel Moves, Stimwave, Titan Medical Inc.

Stimwave calls Nevro patent suit ‘baseless, unfounded’

February 22, 2019 By Fink Densford

Stimwave today responded to a patent infringement suit filed by Nevro (NYSE:NVRO) stating that the claims made against the company are “completely baseless, unfounded and invalid.” In its suit, which was filed in the U.S. District Court for the District of Delaware last week, Nevro claims that Pompano Beach, Fla.-based StimWave infringed on patents related to […]

Filed Under: Legal News, Neuromodulation/Neurostimulation Tagged With: Nevro Corp., Stimwave

Stimwave touts 6 month MIS SCS trial results

January 17, 2019 By Sarah Faulkner

Stimwave today touted six-month data from a trial of its minimally invasive spinal cord stimulator system. The company’s pivotal Surf trial compared a variety of waveform options without the need for separate trial devices. Stimwave reported that in the high and low frequency groups, back and leg pain responders were more than 92% and 86%, […]

Filed Under: Clinical Trials, Featured, Pain Management Tagged With: Stimwave

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy